chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea; Headache; Dizziness; Severe pain all over the body; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), HEADACHE (Headache), DIZZINESS (Dizziness), MYALGIA (Severe pain all over the body) and FATIGUE (Tiredness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 025J20ZA) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included OMEPRAZOLE, HYDROCHLOROTHIAZIDE, SULFAMETHOXAZOLE;TRIMETHOPRIM and CITALOPRAM HYDROBROMIDE for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced NAUSEA (Nausea), HEADACHE (Headache), DIZZINESS (Dizziness), MYALGIA (Severe pain all over the body) and FATIGUE (Tiredness). On 09-Feb-2021, NAUSEA (Nausea) and DIZZINESS (Dizziness) had resolved. On 11-Feb-2021, MYALGIA (Severe pain all over the body) and FATIGUE (Tiredness) had resolved. At the time of the report, HEADACHE (Headache) outcome was unknown. Not Provided          No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not applicable.  Patient explained that the pain was similar to the pain after surgery.   This case was linked to US-MODERNATX, INC.-MOD-2021-062314.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-062314:First dose case
cervical radiculopathy followed by myelopathy responding but not completely resolved w/corticosteroid; began months p/inj;
After the shot, pain developed in my left shoulder and arm. I have had pain and restricted movement ever since. Treatment included prednisone, physical therapy, a cortisone shot, MRI, and exercised. This started Jan. 2016 to now Aug. 26, 2016. It is not as bad but still a significant problem.
pt recv vax; immed began crying and devel muscle twitches; high pitched crying persisted for 20 min;
I've had 3 outbreaks of shingles since my initial set, with the last shot in Nov 2022./ Suspected vaccination failure; I've had 3 outbreaks of shingles since my initial set; This serious case was reported by a consumer via sales rep and described the occurrence of vaccination failure in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (8 prior cases of shingles).   In NOV-2022, the patient received the 2nd dose of Shingrix. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: I've had 3 outbreaks of shingles since my initial set, with the last shot in Nov 2022./ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: I've had 3 outbreaks of shingles since my initial set). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: GSK receipt date: 07-JUN-2023 The patient enquired that is there another set of Shingrix recommended if the 1st vaccinations did not worked as she had 3 outbreaks of shingles since initial set. The patient also enquired that, how long does shingles last. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.
Body aches; Stiffness; Disorientation; Unsteadiness when she stands; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), MUSCULOSKELETAL STIFFNESS (Stiffness), DISORIENTATION (Disorientation), BALANCE DISORDER (Unsteadiness when she stands) and HEADACHE (Slight headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019F21A, 023M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches), MUSCULOSKELETAL STIFFNESS (Stiffness), DISORIENTATION (Disorientation), BALANCE DISORDER (Unsteadiness when she stands) and HEADACHE (Slight headache). At the time of the report, PAIN (Body aches), MUSCULOSKELETAL STIFFNESS (Stiffness), DISORIENTATION (Disorientation), BALANCE DISORDER (Unsteadiness when she stands) and HEADACHE (Slight headache) outcome was unknown.            Concomitant medications were not provided.  Treatment medication was not provided
bloody stool, sweating, bowel is black, no apatite,  vomiting COVID test positive  just went back to the Doctor and COVID test negative Pain in Neck  Cough and sneezing but I think that's unrelated to the Vaccine.
Acute onset tonic clonic muscle contraction asso with grimacing and flexion of wrists, knees, hips. Vasovagal posturing. Reversal promptly with smelling salts.
The child is a refugee and was vaccinated with MMR on 3 Sept 2021.  Patient developed moderate illness on and around 13 Sept and was admitted to hospital and diagnosed with Measles and COVID-19.
Day 1 - injection site pain high Day 2 - injection site pain moderate Day 3 - arm pain, itching, swelling, and rash ("Covid Arm) high Day 4 - continued Day 5 - itching, swelling, and rash ("Covid Arm) moderate Day 6 - itching, swelling, and rash ("Covid Arm) moderate Day 7 - itching, swelling, and rash ("Covid Arm) mild Day 8 - itching, swelling, and rash ("Covid Arm) mild
Chronic intense pain from shoulder to 7-8" down arm; This was the 1st time pt has been vaxed for influenza; pt stated that the pain started immed p/receiving the shot; pt exp limited movement in that arm, difficulty lifting arm overhead;
Headache, Arthralgia, Fever, NauseaVomiting, Tachycardia, fatigue, chills Narrative:  Other Relevant History:
Pt started complaining of cough and weakness about 30 minutes after the administration of flu shot. Pt had hives on his abdomen and buttocks, and also swelling of left thigh where flu shot was administered. Gave pt 5 ml of BENADRYL, administered 0.15mg of epinephrine on his right thigh, and administered albuterol via nebulizer. Then cough and hives subsided and went home around 2:15pm. Pt went to ER since pt started having fever, cough, rash, pain and swelling of his left thigh again around 7pm at night.
I received a Singrix vaccination, a pneumonia vaccination, and a Sr flu shot on 10/1/2020. I repeatedly asked if giving all 3 at once was advisable and was told it was "done all the time." Within 90 minutes, I could not lift my arms. I had terribly pain from above my elbows, drawing a line straight through, meaning my entire chest area, back area, and up the back of the neck. I could not touch my chin to my chest. I was nauseous. The next morning, I was running a fever of 100.6 and went to Urgent Care where they diagnosed me as having a reaction to the vaccinations. They listened to heart and lungs and did not perform a COVID test. They said the onset was not in keeping with the COVID's onset, and I had been exposed and have been very careful being almost 68 years old. I slept all day Friday, as well as most of Saturday and Sunday. Yesterday, 10/5, I started feeling somewhat better but was still very sore in the injection areas and back of my neck. Finally, today, October 6th, I'm feeling somewhat better. The fever subsided on Sunday.
per mom pt began fever of 105 that cont for  4 days p/vax given;mom was givning APAP;pt was seen the next day by MD & Ibuprofen & APAP together was recommended;
Extremely sore arm, large bump around injection site (slightly smaller than a golf ball), bump is warm to the touch
Severe shoulder pain about 4 hrs after shot. 1 week later still in pain.
Left arm swollen hot red and tender. Started after shots last week. Taking BENADRYL and TYLENOL. Feels like things are improving, not as itchy or red today. No throat swelling, difficulty breathing, tongue, or lip swelling.
pt recv vax; 6 hr p/ vax T 102; devel area on rt anterior thigh approx 10cmx10cm of erythema, minimally indurated; given lorabid 200mg one BID for possible cellulitis ;
patient report that his heart rate jumped to 80> and he got a migraine right after receiving the immunization
She has a lymph node in her armpit where everything started that is a little enlarged; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as single dose at the age of 67-years-old for covid-19 immunisation; crizotinib (XALKORI), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 200 mg for an unspecified indication. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient stated she has another CAT scan scheduled for next month. She has a lymph node in her armpit where everything started that is a little enlarged. It was found in her last CAT scan. Her doctor thought it could be due to her COVID vaccine but she is not sure since she got the vaccine back in Mar2021. The action taken in response to the event for crizotinib was unknown. Outcome of the event was unknown.  The lot number for the vaccine BNT162B2, was not provided and will be requested during follow up.
5 days after 1st vaccine she started to have a headache and experienced unexplained falls, 6 days after the 2nd vaccine she had continuous seizures and is now on a vent in Medical Center being treated for possible autoimmune encephalitis, but no cause can be found.
Had immediate injection site pain which progresses to limited range of motion and pain in left shoulder.; Had immediate injection site pain which progresses to limited range of motion and pain in left shoulder.; Had immediate injection site pain which progresses to limited range of motion and pain in left shoulder.; By 8pm experienced all over myalgia and fatigue and chills.; By 8pm experienced all over myalgia and fatigue and chills.; By 8pm experienced all over myalgia and fatigue and chills.; bursitis; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A female patient received BNT162b2 (COMIRNATY), on 24May2022 at 11:00 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "PCOS" (unspecified if ongoing). Concomitant medication(s) included: CELEXA [CITALOPRAM HYDROBROMIDE] oral; ESTRADIOL; PROGESTERONE. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete but unknown manufacturer), for COVID-19 Immunization. The following information was reported: MYALGIA (non-serious), FATIGUE (non-serious), CHILLS (non-serious) all with onset May2022, outcome "recovering" and all described as "By 8pm experienced all over myalgia and fatigue and chills."; VACCINATION SITE PAIN (non-serious), ARTHRALGIA (non-serious) all with onset May2022, outcome "recovering" and all described as "Had immediate injection site pain which progresses to limited range of motion and pain in left shoulder."; JOINT RANGE OF MOTION DECREASED (non-serious) with onset May2022, outcome "not recovered", BURSITIS (non-serious) with onset May2022, outcome "not recovered" and all described as "bursitis". Therapeutic measures were taken as a result of vaccination site pain, joint range of motion decreased, arthralgia, myalgia, fatigue, chills, bursitis.  Additional information: Took 1000mg acetaminophen and hydrated. Symptoms resolved slightly by morning however bursitis in should persists with limited range of motion.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pulsate tinnitus; red rash; itchy rash; hot rash; arm rash (2x3 inches); This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (pulsate tinnitus), RASH ERYTHEMATOUS (red rash), RASH (hot rash), RASH PRURITIC (itchy rash) and RASH (arm rash (2x3 inches)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.     On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced RASH ERYTHEMATOUS (red rash), RASH (hot rash), RASH PRURITIC (itchy rash) and RASH (arm rash (2x3 inches)). On 03-Mar-2021, the patient experienced TINNITUS (pulsate tinnitus). On 25-Feb-2021, RASH ERYTHEMATOUS (red rash), RASH (hot rash) and RASH PRURITIC (itchy rash) had resolved. At the time of the report, TINNITUS (pulsate tinnitus) and RASH (arm rash (2x3 inches)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included muscle relaxer. Concomitant medications included muscle relaxer.   This case was linked to MOD-2021-046388 (Patient Link).
Apprx. 12 hours after receiving the vaccine I started running a low grade temp. The highest it got was 100.4.  I also had severe headache, body aches and fatigue.
no adverse event; HCP calling to report AE for patient who received VAXELIS PFS and VAXNEUVANCE. Improperly stored vaccines were administered to patient on 08SEP2023. No side effects reported. Operator of Device was a Health Professional. No other medical information; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions  and concomitant therapies were not reported.  On 08-SEP-2023, the patient started therapy with diphtheria toxoid (+) hepatitis B virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) injection,  (strength, and route of administration were not provided); lot #U7392AA, expiration date: 31-MAY-2025, administered for prophylaxis and  pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection (strength, and route of administration were not provided), lot #X011332, expiration date: 01-JAN-2025, administered for prophylaxis. The vaccines were improperly stored (Temperature 12.1 Celsius degrees for 13 minutes and 13.1 Celsius degrees for 13 minutes). There was also previous temperature excursion reported. No side effects reported. ; Sender's Comments:  US-009507513-2309USA008760:
Lump at injection site, red wheal approximately 1&1/2 inches across. Probable allergic reaction.
This case was reported by a consumer via call center representative and described the occurrence of fatigue in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was unknown. It was unknown if the reporter considered the fatigue to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter was speaking with his pharmacist about side effects to SHINGRIX and the pharmacist told him that one woman was so tired that, she had to lie in bed for the next day. This case is 1 of the 4 cases reported by the same reporter.
started having allergic reaction; Swollen injection site; Itchy injection site; Red injection site; Pain in her whole body; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (started having allergic reaction) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced MYALGIA (Pain in her whole body). On 02-Apr-2021, the patient experienced HYPERSENSITIVITY (started having allergic reaction) (seriousness criterion medically significant), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE ERYTHEMA (Red injection site). In April 2021, HYPERSENSITIVITY (started having allergic reaction), VACCINATION SITE SWELLING (Swollen injection site), VACCINATION SITE PRURITUS (Itchy injection site), VACCINATION SITE ERYTHEMA (Red injection site) and MYALGIA (Pain in her whole body) had resolved.    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  A day after the first dose the patient had pain in whole body. Moreover, after ten days of getting the first dose, she started having allergic reaction, the injection site was red, swollen and itchy. These symptoms subsided after one week. Treatment information was not provided. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-141740 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
hives on abdomen, hips, legs, arms pruritus; no fever noted, soaked in tub & used rubbing alcohol; unable to get to MD; no transportation; onset 22OCT92 p/lunch 23OCT92AM all hives gone;
Patient (who is an MD) described reaction as hypersensitivity Type 3 with full body rash.  She was treated with benadryl, zyrtec and prednisone.
arm pain; This is a spontaneous report from a contactable consumer or other non healthcare professional reporting for herself. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 24Jun2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, receiving the first injection of the Pfizer covid-19 vaccine yesterday (24Jun2021) and then experiencing arm pain, approximately on Jun2021 which she treated with ibuprofen. Reporter wanted to know was it ok to take ibuprofen after getting the Pfizer covid-19 vaccine. Therapeutic measures were taken as a result of arm pain; treatment included Ibuprofen. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1.5 hours after vaccination, became dizzy. As time went on, dizziness increased. When she laid down and closed eyes, spinning began and she became nauseated. After calling MD fell asleep.
ischemic stroke; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team. The reporter is the patient.  A 68 year-old male patient, a former Pfizer employee, received bnt162b2 (BNT162B2), administration date 12Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), administration date: 21Jan2021, when the patient was 67 years old, for Covid-19 immunization. The following information was reported: ISCHAEMIC STROKE (hospitalization) with onset 25Mar2021, outcome "recovered", described as "ischemic stroke". The event "ischemic stroke" was evaluated at the physician office visit. The patient reported that after his second dose of the purple cap Pfizer Covid-19 vaccine that he had an ischemic stroke five and a half weeks afterwards. The stroke was treated pretty rapidly and he has done fine with the recovery. Caller states that he has never had any health event before this and the cardiologist have run every test that he could but have not been able to answer what has caused him to have the ischemic stroke. He had a CAT scan and they ran a battery of tests while he was in the hospital for part of two days and one night. He has visited his cardiologist 3-4 times who has put him on apixaban (ELIQUIS) as a prevention for possible future events. He has not found out why it happened. He was told by the doctors that they did not think that the vaccine had anything to do with the stroke. They have not determined what triggered the stroke. He stated that he wanted to get a booster dose but he is nervous about that with what happened, he is hesitant and wary about getting the booster dose of the purple cap Pfizer Covid-19 vaccine and has heard that it's better to mix the Covid-19 vaccines with the booster dose and is more effective to do so. He asked if ischemic stroke is a side effect of the purple cap Pfizer Covid-19 vaccine and wanted to know what is the risk of having a stroke with the purple cap booster dose Pfizer Covid-19 vaccine. He wanted to know if one had an ischemic stroke does it increase chances to have another with booster. He stated that he is considering the booster and the cardiologist ran a titer and it was pretty low. The patient stated that the cardiologist is encouraging him to get another vaccine as his titer had dropped to 179. It has been eight months since his last dose. The patient underwent the following laboratory tests and procedures: antibody test: (2021) dropped to 179, notes: cardiologist ran a titer and it was pretty low; computerised tomogram: (2021) unknown results; laboratory test: (2021) unknown results. Therapeutic measures were taken as a result of ischaemic stroke.  The lot number for bnt162b2 was not provided and will be requested during follow up.